نتایج جستجو برای: fhbp

تعداد نتایج: 154  

Journal: :The Journal of infectious diseases 2009
Ellen Murphy Lubomira Andrew Kwok-Leung Lee Deborah A Dilts Lorna Nunez Pamela S Fink Karita Ambrose Ray Borrow Jamie Findlow Muhamed-Kheir Taha Ala-Eddine Deghmane Paula Kriz Martin Musilek Jitka Kalmusova Dominique A Caugant Torill Alvestad Leonard W Mayer Claudio T Sacchi Xin Wang Diana Martin Anne von Gottberg Mignon du Plessis Keith P Klugman Annaliesa S Anderson Kathrin U Jansen Gary W Zlotnick Susan K Hoiseth

BACKGROUND Recombinant forms of Neisseria meningitidis human factor H binding protein (fHBP) are undergoing clinical trials in candidate vaccines against invasive meningococcal serogroup B disease. We report an extensive survey and phylogenetic analysis of the diversity of fhbp genes and predicted protein sequences in invasive clinical isolates obtained in the period 2000-2006. METHODS Nucleo...

2014
Peter Boan Norhaliza Metasan Simone Tempone Gerry Harnett David J Speers Anthony D Keil

BACKGROUND PorA, fetA and fHbp are three antigen encoding genes useful for meningococcal typing and FHbp is an important component of meningococcal B vaccines. METHODS We performed sequence analysis of meningococcal porA, fetA and fHbp genes on 128 isolates from Western Australia, relating results to age, gender, race and geographic region. RESULTS We found predominantly PorA subtypes P1.22...

Journal: :Journal of immunology 2012
Lisa A Lewis Matthew Carter Sanjay Ram

Neisseria meningitidis inhibits the alternative pathway (AP) of complement using diverse mechanisms, including expression of capsule (select serogroups), Neisserial surface protein A (NspA), factor H (fH) binding protein (fHbp), and lipooligosaccharide (LOS) sialylation. The contribution of the latter three molecules in AP regulation in encapsulated meningococci was studied using isogenic mutan...

2010
Lisa A. Lewis Jutamas Ngampasutadol Ruth Wallace Jane E. A. Reid Ulrich Vogel Sanjay Ram

Complement forms an important arm of innate immunity against invasive meningococcal infections. Binding of the alternative complement pathway inhibitor factor H (fH) to fH-binding protein (fHbp) is one mechanism meningococci employ to limit complement activation on the bacterial surface. fHbp is a leading vaccine candidate against group B Neisseria meningitidis. Novel mechanisms that meningococ...

2015
Declan T. Bradley Thomas W. Bourke Derek J. Fairley Raymond Borrow Michael D. Shields Peter F. Zipfel Anne E. Hughes

BACKGROUND Neisseria meningitidis can cause severe infection in humans. Polymorphism of Complement Factor H (CFH) is associated with altered risk of invasive meningococcal disease (IMD). We aimed to find whether polymorphism of other complement genes altered risk and whether variation of N. meningitidis factor H binding protein (fHBP) affected the risk association. METHODS We undertook a case...

Journal: :Infection and immunity 2008
Peter T Beernink Dan M Granoff

Factor H-binding protein (fHbp) is a novel meningococcal vaccine candidate that elicits serum antibodies that activate classical complement pathway bacteriolysis and also inhibit binding of the complement down-regulatory protein, factor H, to the bacterial surface. One limitation of fHbp as a vaccine candidate is antigenic variability, since antibodies to fHbp in the variant 1 (v.1) antigenic g...

2015
Monica Konar Peter T. Beernink Dan M. Granoff Aftab A. Ansari

BACKGROUND Two meningococcal serogroup B vaccines contain Factor H binding protein (FHbp). Binding of Factor H (FH) to FHbp was thought to be specific for human or chimpanzee FH. However, in a previous study an amino acid polymorphism in rhesus macaque FH domain 6, tyrosine at position 352 (Y352) was associated with high binding to FHbp, whereas histidine at position 352 (H352) was associated w...

Journal: :Journal of immunology 2014
Sarika Agarwal Shreekant Vasudhev Rosane B DeOliveira Sanjay Ram

Almost all invasive Neisseria meningitidis isolates express capsular polysaccharide. Ab is required for complement-dependent killing of meningococci. Although alternative pathway evasion has received considerable attention, little is known about classical pathway (CP) inhibition by meningococci, which forms the basis of this study. We engineered capsulated and unencapsulated isogenic mutant str...

Journal: :Infection and immunity 2009
Jutamas Shaughnessy Lisa A Lewis Hanna Jarva Sanjay Ram

Both Neisseria meningitidis and Neisseria gonorrhoeae recruit the alternative pathway complement inhibitory protein factor H (fH) to their surfaces to evade complement-dependent killing. Meningococci bind fH via fH binding protein (fHbp), a surface-exposed lipoprotein that is subdivided into three variant families based on one classification scheme. Chimeric proteins that comprise contiguous do...

2013
Annaliesa S. Anderson Li Hao Qin Jiang Shannon L. Harris Thomas R. Jones John L. Perez Laura York Joseph Eiden Kathrin U. Jansen

Asymptomatic throat carriage of Neisseria meningitidis is common in healthy individuals. In unusual cases, the bacteria become invasive, resulting in life-threatening disease. Effective meningococcal serogroup B (MnB) vaccines should provide broad protection against disease-causing strains and may confer indirect protection by impacting carriage and subsequent transmission. Factor H binding pro...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید